Tag: Dr. Sharvil Patel
Zydus seeks DCGI’s EUA for world’s first Plasmid DNA based COVID-19...
The company has presented interim results from Phase III clinical trials in over 28,000 volunteers in a study carried out in more than 50 clinical sites spread across the country and during the peak of second wave of COVID-19.......................
Zydus launches Ujvira, a breakthrough biosimilar for breast cancer treatment
The world’s first biosimilar Antibody Drug Conjugate of Trastuzumab Emtansine will be priced at nearly 80% less than the currently available option in the market.......................
Zydus’s COVID-19 drug ‘Virafin’ gets DCGI nod
91.15% of patients treated with PegIFN were RT PCR negative by day 7. A single dose of the antiviral Virafin administered subcutaneously early on shows significant clinical and virological improvement in moderate COVID-19 adult patients.......................
Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b...
Promising interim results from Phase III clinical trials with Pegylated Interferon alpha-2b in COVID-19 show higher clinical improvement.........................